Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
35.44
-0.42 (-1.17%)
At close: Aug 15, 2025, 2:13 PM
Monopar Therapeutics Fail-to-Deliver
Total FTD Shares
1.61K
Below Average
FTD / Avg. Volume
4.22%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Monopar Therapeutics Inc. has
1,611
shares failed to deliver, representing 4.22%
of the average daily volume of
38,174
shares. Over the past year, the monthly average FTD is
29,597
shares, with the current level 95% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 43.73 | 1.61K | -92.00% |
| Jun 30, 2025 | 35.78 | 20.15K | +8509.83% |
| May 27, 2025 | 35.25 | 234 | +95.00% |
| Apr 25, 2025 | 42.71 | 120 | -81.19% |
| Mar 31, 2025 | 36.41 | 638 | +3887.50% |
| Feb 19, 2025 | 44.39 | 16 | -99.00% |
| Jan 31, 2025 | 43.94 | 1.59K | +325.94% |
| Dec 31, 2024 | 22 | 374 | -94.11% |
| Nov 29, 2024 | 22.53 | 6.35K | +209.45% |
| Oct 31, 2024 | 14.57 | 2.05K | -62.45% |
| Sep 30, 2024 | 6.74 | 5.46K | +17.94% |
| Aug 30, 2024 | 2.39 | 4.63K | +418.81% |
| Jul 30, 2024 | 3.5 | 893 | -91.18% |
| Jun 25, 2024 | 4.1 | 10.12K | +4522.83% |
| May 31, 2024 | 3.06 | 219 | -95.85% |
| Apr 16, 2024 | 3.64 | 5.28K | +256.21% |
| Mar 21, 2024 | 3.5 | 1.48K | -98.83% |
| Feb 29, 2024 | 4.15 | 126.66K | +2521.73% |
| Jan 22, 2024 | 1.77 | 4.83K | +606.29% |
| Dec 29, 2023 | 1.7 | 684 | +147.83% |
| Nov 29, 2023 | 1.52 | 276 | -91.05% |
| Oct 16, 2023 | 2.35 | 3.08K | +9.68% |
| Sep 15, 2023 | 3.03 | 2.81K | -95.62% |
| Aug 11, 2023 | 3.55 | 64.15K | +1917.84% |
| Jul 19, 2023 | 4.12 | 3.18K | +160.15% |
| Jun 27, 2023 | 4.33 | 1.22K | -50.06% |
| May 25, 2023 | 4.39 | 2.45K | +68.64% |
| Apr 26, 2023 | 5.7 | 1.45K | +100.97% |
| Mar 30, 2023 | 6.95 | 722 | -28.02% |
| Feb 28, 2023 | 15.65 | 1K | +5800.00% |
| Jan 31, 2023 | 17.9 | 17 | n/a |